Despite efforts to improve therapy, short-term mortality in patients with cardiogenic shock is
still reaching 40–50%. Early recognition and treatment of cardiogenic shock are crucial …

Recognition of cardiogenic shock in the setting of myocardial ischaemia has important
prognostic and therapeutic implications. Mortality remains high in the order of 50%, despite …

Cardiogenic shock is the primary cause of death among patients hospitalized with acute
myocardial infarction. It is defined as tissue hypoperfusion resulting from ventricular pump …

OBJECTIVES: To review a contemporary approach to the management of patients with
cardiogenic shock (CS). DATA SOURCES: We reviewed salient medical literature regarding …

Cardiogenic shock is the leading cause of death among patients hospitalized with acute
myocardial infarction. It is defined as tissue hypoperfusion resulting from ventricular pump …

Cardiogenic shock (CS) is defined as primary cardiac dysfunction leading to critical organ
hypoperfusion and hypoxemia. Diagnostic criteria include persistent hypotension and signs …

Cardiogenic shock is a clinical syndrome characterized by low cardiac output and sustained
tissue hypoperfusion resulting in end-organ dysfunction and death. In-hospital mortality …

Cardiogenic shock is one of the most important complications of acute myocardial infarction
(MI) and acute left ventricular failure (LVF). It threatens the life of 5–10% of patients with ST …

Cardiogenic shock (CS) remains the most common cause of death in patients with acute
myocardial infarction although mortality could be reduced from formerly∼ 80% to 40–50 …

Hemodynamic derangements are defining features of cardiogenic shock. Randomized
clinical trials have examined the efficacy of various therapeutic interventions, from …